scispace - formally typeset
D

Diana V. Pastrana

Researcher at National Institutes of Health

Publications -  57
Citations -  4625

Diana V. Pastrana is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Merkel cell polyomavirus & Antibody. The author has an hindex of 30, co-authored 56 publications receiving 4170 citations. Previous affiliations of Diana V. Pastrana include Government of the United States of America & Laboratory of Molecular Biology.

Papers
More filters
Journal ArticleDOI

Merkel Cell Polyomavirus and Two Previously Unknown Polyomaviruses Are Chronically Shed from Human Skin

TL;DR: An improved rolling circle amplification (RCA) technique to isolate circular DNA viral genomes from human skin swabs identified two previously unknown polyomavirus species that are named human polyomvirus-6 (HPyV6) and HPyV7 and indicate that infection or coinfection with these three skin-tropicpolyomaviruses is very common.
Journal ArticleDOI

Efficient Intracellular Assembly of Papillomaviral Vectors

TL;DR: The results suggest that the intracellular assembly of papillomavirus structural proteins around heterologous reporter plasmids is surprisingly promiscuous and may be driven primarily by a size discrimination mechanism.
Journal ArticleDOI

Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18

TL;DR: The SEAP pseudovirus-based neutralization assay should be a practical method for quantifying potentially protective antibody responses in HPV natural history and prophylactic vaccine studies.
Journal ArticleDOI

Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays

TL;DR: It is demonstrated that Merkel cell polyomavirus is a widespread but previously unrecognized human infection and MCC patients have a markedly elevated MCV IgG response compared with control patients.
Book ChapterDOI

Generation of HPV pseudovirions using transfection and their use in neutralization assays.

TL;DR: This chapter outlines a simple method for production of PsV and their use in a high-throughput papillomavirus neutralization assay, which has similar analytic sensitivity to, and higher specificity than, a standard VLP-based enzyme-linked immunosorbent assay (ELISA).